Cargando…

EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China

Detalles Bibliográficos
Autores principales:	Zhou, D, Shao, T, Shao, H, Tu, Y, Tang, Y, Zhou, J, Malone, DC, Tang, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232813/ http://dx.doi.org/10.1016/j.jval.2022.04.923

Ejemplares similares

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
por: Feng, Shuo, et al.
Publicado: (2023)

Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India
por: Du, Zhanwei, et al.
Publicado: (2023)

Booster Doses and Prioritizing Lives Saved
por: Patel, Minal K.
Publicado: (2021)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
por: Deng, Jie, et al.
Publicado: (2022)

COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022
por: Gálvez, Jubby Marcela, et al.
Publicado: (2023)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

Interim statement on covid-19 vaccine booster doses
Publicado: (2021)

Myopericarditis After COVID-19 Booster Dose Vaccination
por: Sharff, Katie A., et al.
Publicado: (2022)

Interim statement on covid-19 vaccine booster doses
Publicado: (2021)

Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose
por: Ríos, Esther, et al.
Publicado: (2022)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

The ags booster
por: Lee, Y
Publicado: (1989)

Estimation of beam losses and radiation dose to components in the CPS booster
por: Hoyer, F
Publicado: (1969)

Mechanical Solitaire Thrombectomy with Low-Dose Booster Tirofiban Injection
por: Goh, Duck-Ho, et al.
Publicado: (2016)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Rzymski, Piotr, et al.
Publicado: (2021)

Efficacy of COVID-19 vaccine booster doses in older people
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

L’EMA recommande la booster dose avec Spikevax
por: Manus, Jean-Marie
Publicado: (2022)

Why promoting a COVID-19 vaccine booster dose?
por: Loubet, Paul, et al.
Publicado: (2021)

Protein-based vaccine as the booster dose for adults: evidence and beyond
por: Shang, Lianhan, et al.
Publicado: (2022)

Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
por: Abdollahi, Alireza, et al.
Publicado: (2022)

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
por: Mattiuzzi, Camilla, et al.
Publicado: (2023)

Safety and immunogenicity of booster dose in patients with chronic liver disease
por: Cossiga, V., et al.
Publicado: (2023)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Safety of COVID-19 booster dose: is the juice worth the squeeze?
por: Madhi, Shabir A, et al.
Publicado: (2023)

Assessing the acceptability of COVID‐19 vaccine and its booster dose
por: Mubarak, Sawsan, et al.
Publicado: (2023)

The role of hybrid immunity after the administration of the first booster dose
por: Pascucci, D, et al.
Publicado: (2023)

The pros and cons of the second booster dose of the COVID-19 vaccine
por: Mostafavi, Ehsan
Publicado: (2022)

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
por: Zhou, Hui Jun, et al.
Publicado: (2022)

Incidence of COVID-19 Vaccination-Related Uveitis and Effects of Booster Dose in a Tertiary Uveitis Referral Center
por: Chew, Milton C., et al.
Publicado: (2022)

Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination
por: Lazcano-Ponce, Eduardo, et al.
Publicado: (2019)

Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)

Uptake of COVID-19 Booster Dose among Saudi Arabian Population
por: Alshahrani, Najim Z., et al.
Publicado: (2022)

Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia
por: Harapan, Harapan, et al.
Publicado: (2022)

COVID-19 Vaccine Booster Dose Acceptance among Older Adults
por: Sezerol, Mehmet Akif, et al.
Publicado: (2023)

Prevertebral Inflammatory Myofibroblastic Tumor Following COVID Vaccine Booster Dose
por: Sprenger, Flávia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ejrerk4bng3fl3sq172arlopam